Skip to main content
. Author manuscript; available in PMC: 2008 Jun 1.
Published in final edited form as: Gynecol Oncol. 2007 Mar 21;105(3):667–671. doi: 10.1016/j.ygyno.2007.01.039

TABLE 3. Cohort 2, Topotecan Daily × 3.

Dose Level Filgrastim Topotecan (mg/m2/day) Paclitaxel (mg/m2) Cisplatin (mg/m2) Evaluable/Total Pts DLT/Eval Pts
1 Yes 0.5 175 50 6/6 1/6
2 Yes 0.6 175 50 4/4 0/4
3 Yes 0.75 175 50 8/8 0/8
4 Yes 1.0 175 50 5/5 2/4